All Stories

  1. The Benzydamine Experience: A Systematic Review of Benzydamine Abuse

    Article • Current Neuropharmacology, October 2021, Bentham Science Publishers

    Alessio Mosca, John Corkery

  2. ‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports

    Article • Current Neuropharmacology, October 2020, Bentham Science Publishers

    Professor Domenico De Berardis, John Corkery

  3. The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic Cannabinoids’ Information Available Online

    Article • Current Neuropharmacology, March 2020, Bentham Science Publishers

    John Corkery

  4. The use of new psychoactive substances (NPS) in young people and their role in mental health care: a systematic review

    Article • Expert Review of Neurotherapeutics, September 2019, Taylor & Francis

    John Corkery, Amira Guirguis, Dr Duccio Papanti

  5. Characteristics of deaths associated with kratom use

    Article • Journal of Psychopharmacology, August 2019, SAGE Publications

    John Corkery

  6. Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors

    Article • Current Drug Metabolism, November 2018, Bentham Science Publishers

    John Corkery

  7. Cannabis; Epidemiological, Neurobiological and Psychopathological Issues: An Update

    Article • CNS & Neurological Disorders - Drug Targets, August 2017, Bentham Science Publishers

    Dr Duccio Papanti, John Corkery, PhD Cristina Cadoni

  8. Is there a Teratogenicity Risk Associated with Cannabis and Synthetic Cannabimimetics’ (‘Spice’) Intake?

    Article • CNS & Neurological Disorders - Drug Targets, August 2017, Bentham Science Publishers

    Dr Duccio Papanti, John Corkery, PhD Cristina Cadoni

  9. An exploratory study of information sources and key findings on UK cocaine-related deaths

    Article • Journal of Psychopharmacology, June 2017, SAGE Publications

    John Corkery

  10. An international survey on the awareness, use, preference, and health perception of novel psychoactive substances (NPS)

    Article • Human Psychopharmacology Clinical and Experimental, May 2017, Wiley

    John Corkery

  11. A matter of life and death: substance-caused and substance-related fatalities in Ibiza in 2015

    Article • Human Psychopharmacology Clinical and Experimental, May 2017, Wiley

    John Corkery

  12. Is there a potential of misuse for Magnolia officinalis compounds/metabolites?

    Article • Human Psychopharmacology Clinical and Experimental, May 2017, Wiley

    Dr Duccio Papanti, John Corkery

  13. 4,4′-Dimethylaminorex (“4,4′-DMAR”; “Serotoni”) misuse: A Web-based study

    Article • Human Psychopharmacology Clinical and Experimental, May 2017, Wiley

    John Corkery

  14. An insight into the deep web; why it matters for addiction psychiatry?

    Article • Human Psychopharmacology Clinical and Experimental, May 2017, Wiley

    Dr Duccio Papanti, John Corkery

  15. Intended and unintended use of cathinone mixtures

    Article • Human Psychopharmacology Clinical and Experimental, May 2017, Wiley

    Amira Guirguis, John Corkery

  16. From concept(ion) to life after death/the grave: The ‘natural’ history and life cycle(s) of novel psychoactive substances (NPS)

    Article • Human Psychopharmacology Clinical and Experimental, May 2017, Wiley

    Dr Duccio Papanti, John Corkery